The latest closing stock price for Unicycive Therapeutics as of February 21, 2025 is 0.62.
An investor who bought $1,000 worth of Unicycive Therapeutics stock at the IPO in 2021 would have $-895 today, roughly -1 times their original investment - a -43.01% compound annual growth rate over 4 years.
The all-time high Unicycive Therapeutics stock closing price was 5.85 on July 13, 2021.
The Unicycive Therapeutics 52-week high stock price is 1.80, which is 190.3% above the current share price.
The Unicycive Therapeutics 52-week low stock price is 0.20, which is 67.7% below the current share price.
The average Unicycive Therapeutics stock price for the last 52 weeks is 0.72.
An investor who bought $1,000 worth of Unicycive Therapeutics stock at the IPO in 2021 would have $-895 today, roughly -1 times their original investment - a -43.01% compound annual growth rate over 4 years.
The all-time high Unicycive Therapeutics stock closing price was 5.85 on July 13, 2021.
The Unicycive Therapeutics 52-week high stock price is 1.80, which is 190.3% above the current share price.
The Unicycive Therapeutics 52-week low stock price is 0.20, which is 67.7% below the current share price.
The average Unicycive Therapeutics stock price for the last 52 weeks is 0.72.